Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy

Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy

Abstract Background Patients with polymetastatic cancer are most often treated with systemic therapy to improve overall survival and/or delay progression, with palliative radiotherapy reserved for sites of symptomatic disease. Stereotactic ablative radiotherapy (SABR) has shown promise in the treatm...

Full description

Bibliographic Details
Main Authors: Glenn S. Bauman, Mark T. Corkum, Hatim Fakir, Timothy K. Nguyen, David A. Palma
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Cancer
Subjects:
Stereotactic radiotherapy
Cancer
Metastatic disease
Clinical trial (phase I)
Online Access:https://doi.org/10.1186/s12885-021-08020-2

Similar Items

Similar Items